FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely, to gerontology, and can be applied for slowing premature aging in workers of gas producing enterprise. For this purpose crestor (rosuvastatin) in dose 5 mg/day daily, independently from food intake and time of day is administered to patient.
EFFECT: invention ensures reduction of aging rate and normalisation of lipid metabolism in said group of patients.
3 tbl, 2 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF CORRECTING BIOLOGICAL AGE OF ORGANISM AS PREVENTION OF PREMATURE AGEING | 2014 |
|
RU2549667C1 |
| METHOD FOR PREDICTING PREMATURE AGING IN YOUNG AND MIDDLE-AGED MEN ASSOCIATED WITH POLYMORBID CARDIOVASCULAR PATHOLOGY | 2022 |
|
RU2795721C1 |
| METHOD OF DETERMINING PERSON'S BIOLOGICAL AGE AND RATE OF AGING | 2008 |
|
RU2387374C2 |
| METHOD OF ASSESSING AGE-RELATED CHANGES OF HUMAN CARDIOVASCULAR SYSTEM | 2012 |
|
RU2485886C1 |
| METHOD OF TREATING ATHEROSCLEROTIC CHANGES OF CARDIOVASCULAR SYSTEM IN ORDER TO SLOW DOWN ITS AGING | 2023 |
|
RU2817933C1 |
| METHOD OF LIPID METABOLIC DISORDER CORRECTION | 2007 |
|
RU2337696C1 |
| METHOD FOR USING BIOLOGICALLY ACTIVE SUPPLEMENT FOR REABLEMENT OF IRRADIATED PATIENTS | 2004 |
|
RU2275129C2 |
| METHOD OF PERSONIFIED PREDICTION OF CLINICAL EFFECTIVENESS OF NON-ALCOHOLIC FATTY LIVER DISEASE IN PATIENTS WITH METABOLIC SYNDROME | 2020 |
|
RU2737503C1 |
| METHOD FOR PREDICTION OF RISK OF PREMATURE AGING OF YOUNG AND MIDDLE-AGED MEN | 2019 |
|
RU2722879C1 |
| METHOD FOR DETECTING PREDISPOSITION TO THE DEVELOPMENT OF METABOLIC SYNDROME IN THE FORM OF OBESITY IN SCHOOLCHILDREN AGED 7-10 YEARS | 2022 |
|
RU2779085C1 |
